hrcak mascot   Srce   HID

Kratko priopćenje
https://doi.org/10.2478/acph-2019-0020

Antimicrobial assesment of aroylhydrazone derivatives in vitro

SAŠA POLOVIĆ ; Agency for Medicinal Products and Medical Devices of Croatia, Zagreb, Croatia
VANJA LJOLJIĆ BILIĆ ; Department of Microbiology, Faculty of Pharmacy and Biochemistry, University of Zagreb Zagreb, Croatia
ANA BUDIMIR ; Department of General and Inorganic Chemistry, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
DARKO KONTREC ; Department of Organic Chemistry and Biochemistry Ruđer Bošković Institute, PO Box 180, Zagreb, Croatia
NIVES GALIĆ ; Department of Chemistry, Faculty of Science University of Zagreb, Zagreb, Croatia
IVAN KOSALEC ; Department of Microbiology, Faculty of Pharmacy and Biochemistry, University of Zagreb Zagreb, Croatia

Puni tekst: engleski, pdf (302 KB) str. 277-285 preuzimanja: 123* citiraj
APA 6th Edition
POLOVIĆ, S., LJOLJIĆ BILIĆ, V., BUDIMIR, A., KONTREC, D., GALIĆ, N. i KOSALEC, I. (2019). Antimicrobial assesment of aroylhydrazone derivatives in vitro. Acta Pharmaceutica, 69 (2), 277-285. https://doi.org/10.2478/acph-2019-0020
MLA 8th Edition
POLOVIĆ, SAŠA, et al. "Antimicrobial assesment of aroylhydrazone derivatives in vitro." Acta Pharmaceutica, vol. 69, br. 2, 2019, str. 277-285. https://doi.org/10.2478/acph-2019-0020. Citirano 09.08.2020.
Chicago 17th Edition
POLOVIĆ, SAŠA, VANJA LJOLJIĆ BILIĆ, ANA BUDIMIR, DARKO KONTREC, NIVES GALIĆ i IVAN KOSALEC. "Antimicrobial assesment of aroylhydrazone derivatives in vitro." Acta Pharmaceutica 69, br. 2 (2019): 277-285. https://doi.org/10.2478/acph-2019-0020
Harvard
POLOVIĆ, S., et al. (2019). 'Antimicrobial assesment of aroylhydrazone derivatives in vitro', Acta Pharmaceutica, 69(2), str. 277-285. https://doi.org/10.2478/acph-2019-0020
Vancouver
POLOVIĆ S, LJOLJIĆ BILIĆ V, BUDIMIR A, KONTREC D, GALIĆ N, KOSALEC I. Antimicrobial assesment of aroylhydrazone derivatives in vitro. Acta Pharm. [Internet]. 2019 [pristupljeno 09.08.2020.];69(2):277-285. https://doi.org/10.2478/acph-2019-0020
IEEE
S. POLOVIĆ, V. LJOLJIĆ BILIĆ, A. BUDIMIR, D. KONTREC, N. GALIĆ i I. KOSALEC, "Antimicrobial assesment of aroylhydrazone derivatives in vitro", Acta Pharmaceutica, vol.69, br. 2, str. 277-285, 2019. [Online]. https://doi.org/10.2478/acph-2019-0020

Sažetak
Aroylhydrazones 1–13 were screened for antimicrobial and antibiofilm activities in vitro. N-(2-hydroxy-phenylmethylidene)-3-pyridinecarbohydrazide (2), N-(5-chloro-2-hydroxyphenyl-methylidene)-3-pyridinecarbohydrazide (10), N-(3,5-chloro-2-hydroxyphenylmethylidene)-3-pyridinecarbohydrazide (11), and N-(2-hydroxy-5-nitrophenylmethylidene)-3-pyridinecarbohydrazide (12) showed antibacterial activity against Escherichia coli, with MIC values (in µmol mL–1) of 0.18–0.23, 0.11–0.20, 0.16–0.17 and 0.35–0.37, resp. Compounds 11 and 12, as well as N-(2-hydroxy-3-methoxyphenylmethylidene)-3-pyridinecarbohydrazide (6) and N-(2-hydroxy-5-methoxyphenylmethylidene)-3-pyridinecarbohydrazide (8) showed antibacterial activity against Staphylococcus aureus, with the lowest MIC values of 0.005–0.2, 0.05–0.12, 0.06–0.48 and 0.17–0.99 µmol mL–1. N-(2-hydroxy-5-methoxyphenylmethylidene)-3-pyridinecarbohydrazide (7) showed antifungal activity against both fluconazole resistant and susceptible C. albicans strains with IC90 range of 0.18–0.1 µmol mL–1. Only compound 11 showed activity against C. albicans ATCC 10231 comparable to the activity of nystatin (the lowest MIC 4.0 ×10–2 vs. 1.7 × 10–2 µmol mL–1). Good activity regarding multi-resistant clinical strains was observed for compound 12 against MRSA strain (MIC 0.02 µmol mL–1) and compounds 2, 6 and 12 against ESBL+ E. coli MFBF 12794, with the lowest MIC for compound 12 (IC50 0.16 µmol mL–1). Anti-biofilm activity was found for compounds 2 (MBFIC 0.015–0.02 µmol mL–1 against MRSA) and 12 (MBFIC 0.013 µmol mL–1 against EBSL+ E. coli). In the case of compound 2 against MRSA biofilm formation, MBFIC values were comparable to those of gentamicin sulphate, whereas in the case of compound 12 and EBSL+ E. coli even more favourable activity compared to gentamicin was observed.

Ključne riječi
aroylhydrazones; antimicrobial; antibiofilm; MDR strains

Hrčak ID: 217029

URI
https://hrcak.srce.hr/217029

Posjeta: 274 *